cannabis-based-therapy | Media Room

Tagged cannabis-based-therapy

Press Release Aug 26, 2020

GB Sciences Files Provisional Patent Application for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome (ARDS), the Leading Cause of Hospitalization and Deaths, Utilizing Its Cannabinoid Containing Complex Mixtures (CCCM™)

Based on data from a two-year study, GBS's CCCM were designed for the treatment of Cytokine Storm Syndromes, while preserving anti-viral immune reactions

Press Release Jul 20, 2020

GB Sciences Announces Issuance of US Patent for Its Proprietary Pain Formulations for the 560 Billion Dollar Chronic Pain Treatment Market

This marks GB Sciences' second US Patent approval for a cannabis-based complex mixture, further solidifying both GB Sciences' Drug Discovery platform and its intellectual property patent portfolio.

First
Prev

Next
Last